SCHEMBL9263261

SCHEMBL9263261

COc1ccc(CCCNC[C@@H](C)CO)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ADRB2 P07550 4/20 0.53
ADRB1 P08588 3/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SLC22A1 O15245 1/20 0.52
CHRM2 P08172 1/20 0.52
CYP3A4 P08684 1/20 0.52
CHRM1 P11229 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
SLC6A4 P31645 1/20 0.52
OPRM1 P35372 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HIF1A Q16665 1/20 0.52
ATM Q13315 1/20 0.50
MAPT P10636 1/20 0.49
KMT2A Q03164 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9262404 1.00 POLB (0.55) POLBKDM4EADRB2ADRB1LMNA
SCHEMBL9262399 1.00 POLB (0.55) POLBKDM4EADRB2ADRB1LMNA
SCHEMBL10553168 0.86 STAT3 (0.57) POLBKDM4EADRB2ADRB1LMNA
SCHEMBL27432980 0.81 KDM4E (0.66) POLBKDM4EADRB2ALDH1A1ATM
Hydrochloric Acid SCHEMBL9782076 0.81 SLC2A1 (0.65) POLBKDM4EADRB2ALDH1A1CYP3A4
SCHEMBL9829336 0.81 POLB (0.53) POLBKDM4EATMMAPTKMT2A
SCHEMBL11432643 0.80 ADRB2 (0.57) KDM4EADRB2ADRB1LMNAALDH1A1
Hydrochloric Acid SCHEMBL9829893 0.80 POLB (0.51) POLBKDM4EATMMAPTKMT2A
SCHEMBL11811971 0.79 SLC2A1 (0.68) POLBKDM4EADRB2ALDH1A1CYP3A4
SCHEMBL9700731 0.78 ADRB2 (0.66) KDM4EADRB2ADRB1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405866-A Administering with cytostatic drugs to treat drug resistant tumors HOFFMANN-LA ROCHE INC. (US) 1995-04-11 US disclosed
US-5302727-A For use with antitumor agents HOFFMANN-LA ROCHE INC. (US) 1994-04-12 US disclosed
EP-0523493-A1 Dithianes F. HOFFMANN-LA ROCHE AG (CH) 1993-01-20 EP disclosed